The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Pluripotent Stem Cell Platforms for Drug Discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Utilization of human induced pluripotent stem cells (hiPSCs) and their derivatives for drug discovery, cell therapy, and disease modeling present a potentially invaluable resource, but existing limitations to their use include conceptual biases, technological limitations, process heterogeneity, rudimentary control over cell fate, and substantial cost7,8.”
From Induced pluripotency in the context of stem cell expansion bioprocess development, optimization, and manufacturing: a roadmap to the clinic (2021) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196
Organogenesis in a dish: Modeling development and disease using organoid technologies
Lancaster, M. A., & Knoblich, J. A. (2014) · Science · doi:10.1126/science.1247125 · Cited by 2,931
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.053 · Cited by 2,408
Vascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., et al. (2013) · Nature · doi:10.1038/nature12271 · Cited by 2,170
Organoid models of human and mouse ductal pancreatic cancer
Boj, S. F., Hwang, C.-I., Baker, L. A., Chio, I. I. C., Engle, D. D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M. S., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.021 · Cited by 2,150
Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure
Qian, X., Nguyen, H. N., Song, M. M., Hadiono, C., Ogden, S. C., Hammack, C., Yao, B., Hamersky, G. R., Jacob, F., Zhong, C., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.032 · Cited by 2,127
A ROCK inhibitor permits survival of dissociated human embryonic stem cells
Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J. B., Nishikawa, S., Nishikawa, S.-I., Muguruma, K., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1310 · Cited by 2,055
Eiraku, M., Watanabe, K., Matsuo-Takasaki, M., Kawada, M., Yonemura, S., Matsumura, M., Wataya, T., Nishiyama, A., Muguruma, K., & Sasai, Y. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.09.002 · Cited by 1,522
Organoids as an in vitro model of human development and disease
Fatehullah, A., Tan, S. H., & Barker, N. (2016) · Nature Cell Biology · doi:10.1038/ncb3312 · Cited by 1,508
Human primary liver cancer–derived organoid cultures for disease modeling and drug screening
Broutier, L., Mastrogiovanni, G., Verstegen, M. M., Francies, H. E., Gavarró, L. M., Bradshaw, C. R., Allen, G. E., Arnes-Benito, R., Sidorova, O., Gaspersz, M. P., et al. (2017) · Nature Medicine · doi:10.1038/nm.4438 · Cited by 1,471 · cited 1×
“In addition, organoids derived from patients’ tumor specimens have been used to model different types of cancer, including colorectal carcinoma [70], pancreatic cancer [71], and liver cancer [72].”
Background
Research works printed but not linked: 81
- Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
- Yu, 2007, Induced pluripotent stem cell lines derived from human somatic cells, Science, 318, 1917, 10.1126/science.1151526 · DOI · Paper page
- Thomson, 1998, Embryonic stem cell lines derived from human blastocysts, Science, 282, 1145, 10.1126/science.282.5391.1145 · DOI · Paper page
- Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
- Chen, 2014, Developmental insights from early mammalian embryos and core signaling pathways that influence human pluripotent cell growth and differentiation, Stem Cell Res., 12, 610, 10.1016/j.scr.2014.02.002 · DOI
- Narva, 2010, High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity, Nat. Biotechnol., 28, 371, 10.1038/nbt.1615 · DOI · Paper page
- Draper, 2004, Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells, Nat. Biotechnol., 22, 53, 10.1038/nbt922 · DOI · Paper page
- Zhang, 2009, Functional cardiomyocytes derived from human induced pluripotent stem cells, Circ. Res., 104, e30, 10.1161/CIRCRESAHA.108.192237 · DOI · Paper page
- Lee, 2010, Induced pluripotent stem cell technology for the study of human disease, Nat. Methods, 7, 25, 10.1038/nmeth.f.283 · DOI
- Inoue, 2011, The use of induced pluripotent stem cells in drug development, Clin. Pharmacol. Ther., 89, 655, 10.1038/clpt.2011.38 · DOI · Paper page
- Zheng, 2013, Phenotypic screens as a renewed approach for drug discovery, Drug Discov. Today, 18, 1067, 10.1016/j.drudis.2013.07.001 · DOI · Paper page
- Ying, 2017, The art of capturing pluripotency: creating the right culture, Stem Cell Rep., 8, 1457, 10.1016/j.stemcr.2017.05.020 · DOI
- Tesar, 2007, New cell lines from mouse epiblast share defining features with human embryonic stem cells, Nature, 448, 196, 10.1038/nature05972 · DOI · Paper page
- Nichols, 2009, Naive and primed pluripotent states, Cell Stem Cell, 4, 487, 10.1016/j.stem.2009.05.015 · DOI · Paper page
- Chen, 2012, Non-colony type monolayer culture of human embryonic stem cells, Stem Cell Res., 9, 237, 10.1016/j.scr.2012.06.003 · DOI
- Androutsellis-Theotokis, 2006, Notch signalling regulates stem cell numbers in vitro and in vivo, Nature, 442, 823, 10.1038/nature04940 · DOI · Paper page
- Kunova, 2013, Adaptation to robust monolayer expansion produces human pluripotent stem cells with improved viability, Stem Cells Transl. Med., 2, 246, 10.5966/sctm.2012-0081 · DOI
- Lee, 2012, Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression, Nat. Biotechnol., 30, 1244, 10.1038/nbt.2435 · DOI · Paper page
- Hoing, 2012, Discovery of inhibitors of microglial neurotoxicity acting through multiple mechanisms using a stem-cell-based phenotypic assay, Cell Stem Cell, 11, 620, 10.1016/j.stem.2012.07.005 · DOI
- Charbord, 2013, High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes, Stem Cells, 31, 1816, 10.1002/stem.1430 · DOI
- Kaufmann, 2015, High-throughput screening using iPSC-derived neuronal progenitors to identify compounds counteracting epigenetic gene silencing in fragile X syndrome, J. Biomol. Screen., 20, 1101, 10.1177/1087057115588287 · DOI · Paper page
- Ma, 2011, High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents, Am. J. Physiol. Heart Circ. Physiol., 301, H2006, 10.1152/ajpheart.00694.2011 · DOI · Paper page
- Harris, 2013, Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays, Toxicol. Sci., 134, 412, 10.1093/toxsci/kft113 · DOI · Paper page
- Doherty, 2015, Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types, Toxicol. Appl. Pharmacol., 285, 51, 10.1016/j.taap.2015.03.008 · DOI
- Sirenko, 2014, High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells, Assay Drug Dev. Technol., 12, 43, 10.1089/adt.2013.520 · DOI
- Choi, 2013, Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells, Hepatology, 57, 2458, 10.1002/hep.26237 · DOI · Paper page
- Ware, 2015, Prediction of drug-induced liver injury in micropatterned co-cultures containing iPSC-derived human hepatocytes, Toxicol. Sci., 145, 252, 10.1093/toxsci/kfv048 · DOI · Paper page
- Mathur, 2015, Human iPSC-based cardiac microphysiological system for drug screening applications, Sci. Rep., 5, 8883, 10.1038/srep08883 · DOI · Paper page
- Zhang, 2013, Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes, Biomaterials, 34, 5813, 10.1016/j.biomaterials.2013.04.026 · DOI · Paper page
- Hinson, 2015, Heart disease. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy, Science, 349, 982, 10.1126/science.aaa5458 · DOI · Paper page
- Carpentier, 2016, Hepatic differentiation of human pluripotent stem cells in miniaturized format suitable for high-throughput screen, Stem Cell Res., 16, 640, 10.1016/j.scr.2016.03.009 · DOI · Paper page
- Mullard, 2015, Stem-cell discovery platforms yield first clinical candidates, Nat. Rev. Drug Discov., 14, 589, 10.1038/nrd4708 · DOI
- Baker, 2007, Adaptation to culture of human embryonic stem cells and oncogenesis in vivo, Nat. Biotechnol., 25, 207, 10.1038/nbt1285 · DOI · Paper page
- Forsyth, 2006, Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities, Cloning Stem Cells, 8, 16, 10.1089/clo.2006.8.16 · DOI · Paper page
- Herron, 2016, Extracellular matrix-mediated maturation of human pluripotent stem cell-derived cardiac monolayer structure and electrophysiological function, Circ. Arrhythm. Electrophysiol., 9, 10.1161/CIRCEP.113.003638 · DOI · Paper page
- Jeziorowska, 2017, Differential sarcomere and electrophysiological maturation of human iPSC-derived cardiac myocytes in monolayer vs. aggregation-based differentiation protocols, Int. J. Mol. Sci., 18, 10.3390/ijms18061173 · DOI
- Loirand, 2015, Rho kinases in health and disease: from basic science to translational research, Pharmacol. Rev., 67, 1074, 10.1124/pr.115.010595 · DOI · Paper page
- Chen, 2014, Alternative cultures for human pluripotent stem cell production, maintenance, and genetic analysis, J. Vis. Exp., 89, 51519
- Braam, 2008, Improved genetic manipulation of human embryonic stem cells, Nat. Methods, 5, 389, 10.1038/nmeth.1200 · DOI
- Liew, 2007, Transient and stable transgene expression in human embryonic stem cells, Stem Cells, 25, 1521, 10.1634/stemcells.2006-0634 · DOI
- Padmanabhan, 2012, Regulation and expression of the ATP-binding cassette transporter ABCG2 in human embryonic stem cells, Stem Cells, 30, 2175, 10.1002/stem.1195 · DOI
- Xia, 2013, Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells, Nat. Cell Biol., 15, 1507, 10.1038/ncb2872 · DOI · Paper page
- Mummery, 2003, Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells, Circulation, 107, 2733, 10.1161/01.CIR.0000068356.38592.68 · DOI · Paper page
- Cimetta, 2009, Micro-bioreactor arrays for controlling cellular environments: design principles for human embryonic stem cell applications, Methods, 47, 81, 10.1016/j.ymeth.2008.10.015 · DOI
- Villa-Diaz, 2009, Microfluidic culture of single human embryonic stem cell colonies, Lab Chip, 9, 1749, 10.1039/b820380f · DOI
- Moledina, 2012, Predictive microfluidic control of regulatory ligand trajectories in individual pluripotent cells, Proc. Natl. Acad. Sci. U. S. A., 109, 3264, 10.1073/pnas.1111478109 · DOI
- van der Meer, 2013, Three-dimensional co-cultures of human endothelial cells and embryonic stem cell-derived pericytes inside a microfluidic device, Lab Chip, 13, 3562, 10.1039/c3lc50435b · DOI
- Dutta, 2017, Disease modeling in stem cell-derived 3D organoid systems, Trends Mol. Med., 23, 393, 10.1016/j.molmed.2017.02.007 · DOI · Paper page
- Koo, 2016, Organoids: a new in vitro model system for biomedical science and disease modelling and promising source for cell-based transplantation, Dev. Biol., 420, 197, 10.1016/j.ydbio.2016.10.017 · DOI
- Takebe, 2014, Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant, Nat. Protoc., 9, 396, 10.1038/nprot.2014.020 · DOI · Paper page
- Lancaster, 2013, Cerebral organoids model human brain development and microcephaly, Nature, 501, 373, 10.1038/nature12517 · DOI · Paper page
- Watson, 2014, An in vivo model of human small intestine using pluripotent stem cells, Nat. Med., 20, 1310, 10.1038/nm.3737 · DOI · Paper page
- Dye, 2015, In vitro generation of human pluripotent stem cell derived lung organoids, Elife, 4, 10.7554/eLife.05098 · DOI · Paper page
- Xu, 2016, Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen, Nat. Med., 22, 1101, 10.1038/nm.4184 · DOI · Paper page
- Chen, 2017, Mouse genetic analysis of bone marrow stem cell niches: technological pitfalls, challenges, and translational considerations, Stem Cell Rep., 9, 1343, 10.1016/j.stemcr.2017.09.014 · DOI
- Scadden, 2014, Nice neighborhood: emerging concepts of the stem cell niche, Cell, 157, 41, 10.1016/j.cell.2014.02.013 · DOI · Paper page
- Schofield, 1978, The relationship between the spleen colony-forming cell and the haemopoietic stem cell, Blood Cells, 4, 7
- Chen, 2018, Concise review: conceptualizing paralogous stem-cell niches and unfolding bone marrow progenitor cell identities, Stem Cells, 36, 11, 10.1002/stem.2711 · DOI
- Ootani, 2009, Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche, Nat. Med., 15, 701, 10.1038/nm.1951 · DOI · Paper page
- Sato, 2009, Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche, Nature, 459, 262, 10.1038/nature07935 · DOI · Paper page
- Zaret, 2002, Regulatory phases of early liver development: paradigms of organogenesis, Nat. Rev. Genet., 3, 499, 10.1038/nrg837 · DOI · Paper page
- Chawla, 2001, Nuclear receptors and lipid physiology: opening the X-files, Science, 294, 1866, 10.1126/science.294.5548.1866 · DOI · Paper page
- Guengerich, 2008, Cytochrome p450 and chemical toxicology, Chem. Res. Toxicol., 21, 70, 10.1021/tx700079z · DOI · Paper page
- Caswell, 2013, Engineering and application of P450 monooxygenases in pharmaceutical and metabolite synthesis, Curr. Opin. Chem. Biol., 17, 271, 10.1016/j.cbpa.2013.01.028 · DOI
- Wlcek, 2014, ATP-binding cassette transporters in liver, Biofactors, 40, 188, 10.1002/biof.1136 · DOI
- Gottesman, 2002, Multidrug resistance in cancer: role of ATP-dependent transporters, Nat. Rev. Cancer, 2, 48, 10.1038/nrc706 · DOI · Paper page
- Borst, 2002, Mammalian ABC transporters in health and disease, Annu. Rev. Biochem., 71, 537, 10.1146/annurev.biochem.71.102301.093055 · DOI · Paper page
- Dean, 2005, Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates, Annu. Rev. Genomics Hum. Genet., 6, 123, 10.1146/annurev.genom.6.080604.162122 · DOI · Paper page
- Chen, 2012, Molecular pathways: regulation and therapeutic implications of multidrug resistance, Clin. Cancer Res., 18, 1863, 10.1158/1078-0432.CCR-11-1590 · DOI · Paper page
- Szakacs, 2006, Targeting multidrug resistance in cancer, Nat. Rev. Drug Discov., 5, 219, 10.1038/nrd1984 · DOI · Paper page
- Burger, 2004, Pharmacokinetic resistance to imatinib mesylate: role of the ABC drug pumps ABCG2 (BCRP) and ABCB1 (MDR1) in the oral bioavailability of imatinib, Cell Cycle, 3, 1502, 10.4161/cc.3.12.1331 · DOI
- Burger, 2004, Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump, Blood, 104, 2940, 10.1182/blood-2004-04-1398 · DOI · Paper page
- Chen, 1997, Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins, J. Biol. Chem., 272, 5974, 10.1074/jbc.272.9.5974 · DOI
- Chen, 2000, Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335), Mol. Pharmacol., 57, 769, 10.1124/mol.57.4.769 · DOI
- Loo, 2005, Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux, J. Membr. Biol., 206, 173, 10.1007/s00232-005-0792-1 · DOI · Paper page
- Ambudkar, 1999, Biochemical, cellular, and pharmacological aspects of the multidrug transporter, Annu. Rev. Pharmacol. Toxicol., 39, 361, 10.1146/annurev.pharmtox.39.1.361 · DOI · Paper page
- Kimchi-Sarfaty, 2007, A “silent” polymorphism in the MDR1 gene changes substrate specificity, Science, 315, 525, 10.1126/science.1135308 · DOI · Paper page
- Dekkers, 2013, A functional CFTR assay using primary cystic fibrosis intestinal organoids, Nat. Med., 19, 939, 10.1038/nm.3201 · DOI · Paper page
- Firth, 2015, Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs, Cell Rep., 12, 1385, 10.1016/j.celrep.2015.07.062 · DOI · Paper page
- Castellani, 2008, Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice, J. Cyst. Fibros., 7, 179, 10.1016/j.jcf.2008.03.009 · DOI · Paper page
- Dujardin, 2011, Splicing defects in the CFTR gene: minigene analysis of two mutations, 1811+1G>C and 1898+3A>G, J. Cyst. Fibros., 10, 212, 10.1016/j.jcf.2010.12.008 · DOI
Cited by
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
Lopes-Pacheco, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01662 · Cited by 535
Drug Repurposing for Rare Diseases
Roessler, H. I., Knoers, N. V. A. M., van Haelst, M. M., & van Haaften, G. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.01.003 · Cited by 269
Intestinal organoids: A new paradigm for engineering intestinal epithelium in vitro
Rahmani, S., Breyner, N. M., Su, H.-M., Verdu, E. F., & Didar, T. F. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.12.006 · Cited by 98
Boussaad, I., Cruciani, G., Bolognin, S., Antony, P., Dording, C. M., Kwon, Y.-J., Heutink, P., Fava, E., Schwamborn, J. C., & Krüger, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-81129-3 · Cited by 42
Colter, J., Murari, K., Biernaskie, J., & Kallos, M. S. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00183-7 · Cited by 33
Metadata
- Authors
- Chen, K. G., Mallon, B. S., Park, K., Robey, P. G., McKay, R. D. G., Gottesman, M. M., & Zheng, W.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 24
- Issue
- 9
- Pages
- 805-820
- ISSN
- 1471-4914
- Cited by
- 43
- References
- 21
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pluripotent Stem Cell Platforms for Drug Discovery. https://app.cochat.ai/papers/10.1016/j.molmed.2018.06.009
- The paper
- Chen, K. G., Mallon, B. S., Park, K., Robey, P. G., McKay, R. D. G., Gottesman, M. M., & Zheng, W. (2018). Pluripotent Stem Cell Platforms for Drug Discovery. Trends in Molecular Medicine. https://doi.org/10.1016/j.molmed.2018.06.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.